Impact of early initiation of sodium-glucose cotransporter 2 inhibitor on cardiovascular outcomes in people with diabetes and known or at risk of atherosclerotic cardiovascular disease: Propensity score matched analysis

ConclusionEarly initiation of SGLT2 inhibitor was associated with lower MACE rates in T2D with known or at risk of ASCVD.

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0277321

Source: PLoS One - November 4, 2022 Category: Biomedical Science Authors: Wen Sun Source Type: research

More News: Biomedical Science | Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Attack | SGLT2 Inhibitors | Sodium | Stroke